Tools for Targeted Delivery of DNA into Mammalian Cells

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$144,888.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43RR018437-01A1
Award Id:
70766
Agency Tracking Number:
RR018437
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
ALPHA UNIVERSE, LLC, 1202 ANN ST, MADISON, WI, 53713
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ALEXEY ZDANOVSKY
(608) 661-0861
ALEXEYZD@TDS.NET
Business Contact:
ALEXEY ZDANOVSKY
(608) 661-0861
ALEXEYZD@MAILBAG.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Viral vectors are the most efficient tools currently available for genetic modification of mammalian cells in vitro and in vivo. However, because protocols for the incorporation of DNA of interest into viral particles are rather lengthy and cumbersome, these vectors have not been extensively used in the area of cell biology. In the area of genetic therapy these vectors remain unchallenged tools, but they are expensive to produce, suffer from the inability to target only chosen types of cells and their application could be associated with substantial health risks. On the contrary, bacteriophage lambda-derived vectors are easy and safe to use. They have a substantial capacity and could be reproducibly obtained in high quantities. For years bacteriophage lambda-based vectors have been used as versatile tools for the delivery of foreign DNA into bacterial, but not into mammalian cells. The purpose of the current proposal is to identify ways to convert bacteriophage lambda from being a general toot in molecular biology to a general toot for cell biology. We intend to prove that provided with means to recognize specific receptors on the surface of mammalian cells and penetrate through the cell membrane, bacteriophage lambda particles will be able to deliver extended DNA sequences into mammalian cells. During Phase I proof of the concept will be achieved through the delivery of DNA capable of directing the synthesis of green fluorescent protein into mammalian cells. During Phase II efforts will be directed towards optimization of such important processes as receptor recognition, membrane penetration, release of DNA from a phage capsid and transport of DNA into the cell nucleus. As a result of these efforts we expect to create a new tool that will allow for efficient shuttling of DNA constructs (including combinatorial libraries) from E. coil into mammalian cells. Also, we expect to lay a foundation for construction of customized bacteriophage-based DNA delivery systems suitable for genetic therapy applications.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government